Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial

Ramon Luengo-Fernandez, Erika Penz, Melissa Dobson, Ioannis Psallidas, Andrew J. Nunn, Nick A. Maskell, Najib M. Rahman
European Respiratory Journal 2019 54: 1801550; DOI: 10.1183/13993003.01550-2018
Ramon Luengo-Fernandez
1Health Economics Research Centre, Nuffield Dept of Population Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ramon Luengo-Fernandez
Erika Penz
2Dept of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Dobson
3Oxford Respiratory Trials Unit, Nuffield Dept of Clinical Medicine, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioannis Psallidas
3Oxford Respiratory Trials Unit, Nuffield Dept of Clinical Medicine, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Nunn
4MRC Clinical Trials Unit, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nick A. Maskell
5Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Najib M. Rahman
3Oxford Respiratory Trials Unit, Nuffield Dept of Clinical Medicine, University of Oxford, Oxford, UK
6Oxford NIHR Biomedical Research Centre, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: najib.rahman@ndm.ox.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 54 no. 2
DOI 
https://doi.org/10.1183/13993003.01550-2018
PubMed 
31097519

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received September 10, 2018
  • Accepted April 30, 2019
  • Published online August 1, 2019.

Article Versions

  • previous version (May 16, 2019 - 08:54).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2019

Author Information

  1. Ramon Luengo-Fernandez1,
  2. Erika Penz2,
  3. Melissa Dobson3,
  4. Ioannis Psallidas3,
  5. Andrew J. Nunn4,
  6. Nick A. Maskell5 and
  7. Najib M. Rahman3,6⇑
  1. 1Health Economics Research Centre, Nuffield Dept of Population Health, University of Oxford, Oxford, UK
  2. 2Dept of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
  3. 3Oxford Respiratory Trials Unit, Nuffield Dept of Clinical Medicine, University of Oxford, Oxford, UK
  4. 4MRC Clinical Trials Unit, University College London, London, UK
  5. 5Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, UK
  6. 6Oxford NIHR Biomedical Research Centre, Oxford, UK
  1. Najib M. Rahman, Oxford Respiratory Trials Unit, Nuffield Dept of Clinical Medicine, University of Oxford, Oxford, OX3 7LE, UK. E-mail: najib.rahman{at}ndm.ox.ac.uk
View Full Text

Article usage

Article usage: May 2019 to January 2021

AbstractFullPdf
May 20195702532
Jun 20192802419
Jul 20191732116
Aug 20191299172106
Sep 201988312895
Oct 20192702523
Nov 20191081412
Dec 2019103107
Jan 202081247
Feb 202046134
Mar 2020801415
Apr 202033135
May 20204795
Jun 20205055
Jul 20204654
Aug 20205844
Sep 20204588
Oct 2020771411
Nov 20207297
Dec 202048146
Jan 202143177

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 54 Issue 2 Table of Contents
European Respiratory Journal: 54 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial
Ramon Luengo-Fernandez, Erika Penz, Melissa Dobson, Ioannis Psallidas, Andrew J. Nunn, Nick A. Maskell, Najib M. Rahman
European Respiratory Journal Aug 2019, 54 (2) 1801550; DOI: 10.1183/13993003.01550-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial
Ramon Luengo-Fernandez, Erika Penz, Melissa Dobson, Ioannis Psallidas, Andrew J. Nunn, Nick A. Maskell, Najib M. Rahman
European Respiratory Journal Aug 2019, 54 (2) 1801550; DOI: 10.1183/13993003.01550-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Articles

  • EmPHasis-10 as a measure of quality of life in PAH
  • EmPHasis-10 health-related quality of life score predicts outcomes in PAH
  • Periostin and airway epithelial function in asthma
Show more Original Articles

Pleural disease

  • Prospective validation of RAPID clinical risk prediction score in pleural infection
  • Complications following symptom-limited thoracentesis using suction
  • PLEASE study of breathlessness in a symptomatic pleural effusion
Show more Pleural disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society